Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • FloodlightGenomics
    Registered Vendor
    • Nov 2015
    • 1

    #1

    High capacity, low cost, targeted NGS

    Hello SEQanswers
    My name is Kurt Lamour and I run a company (Floodlight Genomics) that provides a new low cost option for targeted genetic sequencing (MonsterPlex). MonsterPlex is a single-tube PCR-based technology to amplify 10's to 100's of targets from small amounts DNA (e.g. 20-40ng). Custom indices are added during the multiplex PCR and we currently index up to 6000 samples for pooling (loaded as a single library) on an Illumina or Ion device.

    Total target sizes can be either 80, 380 or 480bp. It depends on your goals and/or the sequencing device and configuration you'd like to use.

    I'm an academic research scientist (molecular epidemiologist) who developed MonsterPlex to better use the huge amount of excess sequence data our lab was producing using WGS and GBS. Thus far we've worked directly with academic research scientists on native grasses, insects, infected plants and large mammals. Any target is fair game!

    Best I can tell, our project costs are low. For example, the cost to analyze 1000 samples for 100 targets (=100,000 data points) is less than $0.10/target at >20X coverage per target. You provide the DNA and the target sequences and we deliver the sample-specific sequence data. MonsterPlex should work equally well on cDNA, making for some interesting RNAseq options - although I've yet to try it.

    Check us out at:

    Floodlightgenomics.com

    Or send me a message if you have questions.
  • james hadfield
    Moderator
    Cambridge, UK
    Community Forum
    • Feb 2008
    • 224

    #2
    Hi Kurt,
    Please get in touch directly. [email protected], @CIgenomics, or http://core-genomics.blogspot.co.uk.
    I'd like to find out more and will take a look.
    James.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      Yesterday, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 05:39 AM
    0 responses
    12 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-13-2026, 09:56 AM
    0 responses
    14 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-09-2026, 11:14 AM
    0 responses
    27 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 09-29-2026, 09:51 AM
    0 responses
    78 views
    0 reactions
    Last Post SEQadmin2  
    Working...